TRANSFERRIN RECEPTOR MEDIATES UPTAKE AND PRESENTATION OF HEPATITIS-B ENVELOPE ANTIGEN BY LYMPHOCYTES-T

被引:90
作者
FRANCO, A
PAROLI, M
TESTA, U
BENVENUTO, R
PESCHLE, C
BALSANO, F
BARNABA, V
机构
[1] UNIV LA SAPIENZA, FDN ANDREA CESALPINO,IST CLIN MED 1,IMMUNOL UNIT, VIALE POLICLIN, I-00161 ROME, ITALY
[2] UNIV LA SAPIENZA, CATTEDRA MED INTERNA, I-00161 ROME, ITALY
[3] IST SUPER SANITA, DEPT HEMATOL & ONCOL, I-00161 ROME, ITALY
关键词
D O I
10.1084/jem.175.5.1195
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human activated T lymphocytes expressing class II molecules are able to present only complex antigens that bind to their own surface receptors, and thus can be captured, internalized, and processed through the class II major histocompatibility complex processing pathway. We have used the antigen-presenting T cell system to identify the viral receptor used by hepatitis B virus (HBV) to enter cells, as well as the sequence of HB envelope antigen (HBenvAg) involved in this interaction. Results show that both CD4+ and CD8+ T clones can process and present HBenvAg to class II-restricted cytotoxic T lymphocytes and that the CD71 transferrin receptor (TfR) is involved in efficient HBenvAg uptake by T cells. Moreover, we provide evidence that the HBenvAg sequence interacting with the T cell surface is contained within the pre-S2 region. Since TfR is also expressed on hepatocytes, it might represent a portal of cellular entry for HBV infection. This system of antigen presentation by T cells may serve as a model to study both lymphocyte receptors used by lymphocytotropic viruses and viral proteins critical to bind them.
引用
收藏
页码:1195 / 1205
页数:11
相关论文
共 62 条
[1]  
ALBERTI A, 1990, SPRINGER SEMIN IMMUN, V12, P5
[2]  
BAIRD A, 1990, NATURE, V348, P344, DOI 10.1038/348344a0
[3]  
BARNABA V, 1989, J IMMUNOL, V143, P2650
[4]   SELECTIVE KILLING OF HEPATITIS-B ENVELOPE ANTIGEN-SPECIFIC B-CELLS BY CLASS-I-RESTRICTED, EXOGENOUS ANTIGEN-SPECIFIC LYMPHOCYTES-T [J].
BARNABA, V ;
FRANCO, A ;
ALBERTI, A ;
BENVENUTO, R ;
BALSANO, F .
NATURE, 1990, 345 (6272) :258-260
[5]  
BARNABA V, 1991, IN PRESS J HEPATOL
[6]  
BRODSKY FM, 1991, ANNU REV IMMUNOL, V9, P707
[7]   THE RELATION BETWEEN MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) RESTRICTION AND THE CAPACITY OF IA TO BIND IMMUNOGENIC PEPTIDES [J].
BUUS, S ;
SETTE, A ;
COLON, SM ;
MILES, C ;
GREY, HM .
SCIENCE, 1987, 235 (4794) :1353-1358
[8]  
CABEZON T, 1990, VACCINES, V90, P199
[9]  
CELIS E, 1988, J IMMUNOL, V140, P1808
[10]  
CHESNUT RW, 1986, ADV IMMUNOL, V39, P51